Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 1—January 2012

Accelerating Control of Pertussis in England and Wales

Helen CampbellComments to Author , Gayatri Amirthalingam, Nick Andrews, Norman K. Fry, Robert C. George, Timothy Harrison, and Elizabeth Miller
Author affiliations: Health Protection Agency, London, UK

Main Article

Figure 1

Figure 1. Changes to routine childhood pertussis immunization programs and notifications of pertussis disease (all ages) and vaccine coverage among children <2 years of age, England and Wales, 1940–2009. DTwP, diphtheria/tetanus/whole-cell pertussis vaccine; DTaP3, diphtheria/tetanus/3-component acellular pertussis vaccine; DTaP5, diphtheria/tetanus/5-component aP vaccine; DTaP3-Hib, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b vaccine; DTaP3-Hib-IPV, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b/inactivated polio vaccine; DTaP3-IPV, diphtheria/tetanus/3-component acellular pertussis/inactivated polio vaccine; DTaP5-IPV, diphtheria/tetanus/5-component acellular pertussis/inactivated polio vaccine.

Main Article

Page created: December 23, 2011
Page updated: December 23, 2011
Page reviewed: December 23, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.